RESTON, Va.--(BUSINESS WIRE)--MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for its fourth quarter and fiscal year ended September 30, 2013.
Highlights for the fourth quarter and the full fiscal year include:
- Fourth quarter revenue grew 28% to $384.3 million; GAAP diluted earnings per share from continuing operations increased 50% to $0.51; and adjusted diluted earnings per share increased 38% to $0.51.
- Fiscal 2013 revenue grew 27% to $1.33 billion; GAAP diluted earnings per share from continuing operations increased 54% to $1.68; and adjusted diluted earnings per share from continuing operations increased 36% to $1.60.
- Cash and cash equivalents totaled $125.6 million at September 30, 2013.
- Signed contract awards reached a record level at $1.9 billion for fiscal 2013 and the sales pipeline remained strong at $2.4 billion at September 30, 2013.
For the fourth quarter of fiscal 2013, revenue increased 28% (30% on a constant currency basis) to $384.3 million, compared to revenue of $300.7 million reported for the same period last year, driven by growth in the Health Segment. Organic revenue growth was 23%. Fiscal 2013 fourth quarter income from continuing operations, net of taxes, totaled $35.6 million, or $0.51 per diluted share. This represents a 50% increase compared to $0.34 reported, on a GAAP basis, for the same period last year.
Revenue for fiscal year 2013 increased 27% (28% on a constant currency basis) to $1.33 billion compared to $1.05 billion reported for fiscal 2012. Fiscal 2013 included approximately $16.0 million in revenue from a terminated contract that the Company excluded from its fiscal 2013 guidance. Fiscal 2013 revenue grew 19% organically compared to the same period last year. Revenue increases for the fiscal year were driven by new work, the expansion of existing contracts, and the acquisition of PSI and Health Management.
For the full fiscal year, income from continuing operations, net of taxes, totaled $117.1 million, or $1.68 per diluted share. This included approximately $0.01 of net legal, settlement and acquisition-related expenses and $0.09 of benefit from a terminated contract that was recorded in the second quarter. Excluding the $0.08 contribution from these items, fiscal 2013 adjusted diluted earnings per share from continuing operations increased 36% to $1.60 compared to adjusted diluted earnings per share from continuing operations of $1.18 reported for fiscal 2012. The year-over-year increase to earnings for the quarter and the year is principally attributable to growth in the Health Segment. A reconciliation to this non-GAAP measure is included in the accompanying financial schedules.
“We are very pleased with the solid financial results for the fourth quarter and fiscal year. Over the last year, we achieved important milestones under our three long-term growth objectives of securing our fair share of work related to the Affordable Care Act, growing our federal services business, and expanding our international operations,” commented Richard A. Montoni, Chief Executive Officer of MAXIMUS.
Health Services Segment
Health Services Segment revenue for the fourth quarter of fiscal 2013 increased 49% to $271.0 million compared to the same period last year. The increase was driven by new work, including contracts supporting the Affordable Care Act in the United States, expansion on existing programs, and the Health Management acquisition. Health Services Segment operating income for the fourth quarter of fiscal 2013 increased 130% to $45.9 million (16.9% operating margin) and benefitted from transactional-based volume growth in the Company’s federal Medicare appeals business and in its state health operations. This compares to $20.0 million (11.0% operating margin) for the same period last year.
For the full fiscal year, Health Services Segment revenue increased 29% to $862.9 million compared to the same period last year. The increase was driven by new work, including contracts supporting the Affordable Care Act in the United States; expansion on existing programs; and, to a lesser extent, acquisitions. For fiscal 2013, Health Services Segment operating income increased 61% to $129.8 million (15.0% operating margin), compared to $80.6 million (12.0% operating margin) for fiscal 2012. Margin expansion in the year was driven principally by the accretive nature of the higher volumes in the Company’s federal Medicare appeals business.
Human Services Segment
Human Services Segment revenue for the fourth quarter of fiscal 2013 decreased 5% to $113.3 million compared to the same period last year. Human Services Segment operating income for the fourth quarter of 2013 decreased to $11.9 million (10.5% operating margin) compared to $21.8 million (18.3% operating margin) for the same period last year. The prior-year period included short-term work in the Company’s U.S. operations that bolstered both revenue and profit in the fourth quarter of fiscal 2012.
For the full fiscal year, Human Services Segment revenue increased 24% to $468.4 million compared to the same period last year, driven principally by the ongoing ramp-up in the United Kingdom, new work in Saudi Arabia and the PSI acquisition. Fiscal 2013 included $16.0 million in GAAP-basis revenue from a terminated contract that the Company excluded from its fiscal 2013 guidance. For the full fiscal year, Human Services Segment operating income totaled $58.1 million (12.4% operating margin) compared to $49.9 million (13.2% operating margin) for fiscal 2012. Both fiscal 2012 and fiscal 2013 included infrequently occurring benefits to operating income. In fiscal 2012, the segment benefitted primarily from reductions to the cost to complete a fixed-price contract, which offset the start-up losses in the United Kingdom. In fiscal 2013, excluding the $10.9 million benefit from the terminated contract, the ongoing margin improvement in the United Kingdom offset the expected lowered margins in Australia and lower margins in the U.S. operations.
Backlog, Sales and Pipeline
Record backlog was $3.4 billion at September 30, 2013, compared to $2.9 billion at September 30, 2012.
Signed contract awards reached a record level in fiscal 2013. Year-to-date signed contract awards at September 30, 2013 totaled $1.9 billion, of which a substantial portion was derived from new work. This compares to $1.4 billion reported for the same period last year. New contracts pending (awarded but unsigned) totaled $362 million at September 30, 2013.
Sales pipeline at September 30, 2013 was $2.4 billion (consisting of $358 million in proposals pending, $32 million in proposals in preparation, and $2.0 billion in opportunities tracking) and includes opportunities across multiple geographies and both segments. This is slightly lower compared to $2.6 billion in sales pipeline reported for the same period last year, due to opportunities converting into new sales. On a sequential basis, the pipeline is slightly higher compared to the third fiscal quarter of 2013.
Balance Sheet and Cash Flows
Cash and cash equivalents at September 30, 2013 totaled $125.6 million, of which approximately 60% were held overseas. For the fourth quarter of fiscal 2013, cash provided by operating activities from continuing operations totaled $32.4 million, with free cash flow of $8.7 million. For the full fiscal year, cash provided by operating activities from continuing operations totaled $121.6 million, with free cash flow of $59.4 million. Days Sales Outstanding (DSO) from continuing operations were 69 days and remain within the Company’s previously stated range of 65 to 80 days.
On August 30, 2013, MAXIMUS paid a quarterly cash dividend of $0.045 per share. On October 8, 2013, the Company announced a $0.045 per share cash dividend, payable on November 29, 2013 to shareholders of record on November 15, 2013.
MAXIMUS repurchased 145,600 shares of the Company’s common stock for approximately $5.5 million during the fourth quarter of fiscal 2013. For the full year, MAXIMUS repurchased 974,498 shares for approximately $32.5 million. At September 30, 2013, the Company had approximately $97 million available for future repurchases under its Board-authorized share repurchase program. All amounts reflect the stock split on June 28, 2013.
Outlook
MAXIMUS is formalizing its fiscal year 2014 revenue and earnings guidance. The Company continues to expect fiscal year 2014 revenue to range between $1.555 billion and $1.650 billion and diluted earnings per share to range between $1.75 and $1.85. This guidance does not include any future mergers and acquisition activity or any significant legal expenses or recoveries.
Mr. Montoni concluded, “With our formalized fiscal 2014 guidance in place, we continue to focus on the areas where we can best maximize shareholder value. We continue to see opportunities in the U.S. and abroad that dovetail nicely with our core capabilities, and we remain confident about our continued growth into fiscal 2014 and beyond.”
Website Presentation, Conference Call and Webcast Information
MAXIMUS will host a conference call this morning, November 15, 2013, at 9:00 a.m. (ET). The call is open to the public and can be accessed under the Investor Relations page of the Company’s website at http://investor.maximus.com or by calling:
877.407.8289 (Domestic)/201.689.8341 (International)
For those unable to listen to the live call, a replay will be available through November 29, 2013. Callers can access the replay by calling:
877.660.6853 (Domestic)/201.612.7415 (International)
Replay
conference ID number: 422475
About MAXIMUS
MAXIMUS is a leading operator of government health and human services programs in the United States, United Kingdom, Canada, Australia and Saudi Arabia. The Company delivers business process services to improve the cost effectiveness, efficiency and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Children's Health Insurance Program (CHIP), Health Insurance BC (British Columbia), as well as welfare-to-work and child support programs around the globe. The Company's primary customer base includes federal, provincial, state, county and municipal governments. Operating under its founding mission of Helping Government Serve the People®, MAXIMUS has approximately 12,000 employees worldwide. For more information, visit www.maximus.com.
Non-GAAP Measures
This release refers to non-GAAP financial measures, including free cash flow, adjusted diluted earnings per share from continuing operations, constant currency and organic growth. We also adjust certain revenue and operating income comparatives to reflect the one-time benefit of a contract termination in the current year.
We have provided a reconciliation of free cash flow to cash provided by operating activities from continuing operations. We believe that free cash flow is a useful basis for investors to compare our performance across periods or across our competitors. Free cash flow shows the effects of the Company’s operations and routine capital expenditure and excludes the cash flow effects of acquisitions, share repurchases, dividend payments and other financing transactions.
We have provided a reconciliation to adjusted diluted earnings per share. We believe that this measure is a useful basis for assessing the Company’s performance excluding the effect of the costs of acquiring PSI and Health Management, as well as net legal and settlement expenses.
To provide constant currency information, we calculate fiscal year 2013 revenue for all international businesses using the exchange rates used in fiscal year 2012. We believe constant currency provides a useful basis for assessing the performance of the business excluding the unpredictable effects of foreign exchange fluctuations.
In order to calculate organic growth, we remove the revenue from the acquired businesses from all periods being compared. We believe organic growth provides a useful basis for assessing the performance of the underlying business.
We have provided a reconciliation of revenue and operating income adjusted for the effects of a termination of a contract. We believe that the presentation of these numbers provides a useful basis for assessing the performance of this segment compared to prior periods or the results of our competitors.
The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operating activities, diluted earnings per share, revenue growth or net income as measures of performance.
Statements that are not historical facts, including statements about the Company's confidence and strategies and the Company's expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company's products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company's actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company's most recent Annual Report filed with the Securities and Exchange Commission, found on www.maximus.com.
MAXIMUS, Inc. | |||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(Dollars in thousands, except per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
Three Months | Year | ||||||||||||||
Ended September 30, | Ended September 30, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Revenue | $ | 384,339 | $ | 300,737 | $ | 1,331,279 | $ |
1,050,145 |
|||||||
Cost of revenue | 266,840 | 216,108 | 945,246 | 762,202 | |||||||||||
Gross profit | 117,499 | 84,629 | 386,033 | 287,943 | |||||||||||
Selling, general and administrative expenses | 59,763 | 42,810 | 197,859 | 157,402 | |||||||||||
Acquisition-related expenses | 668 | 766 | 2,168 | 2,876 | |||||||||||
Legal and settlement expenses/(recoveries), net | — | 1,080 | (202 | ) | 90 | ||||||||||
Operating income from continuing operations | 57,068 | 39,973 | 186,208 | 127,575 | |||||||||||
Interest and other income, net | 407 | 1,084 | 2,851 | 4,176 | |||||||||||
Income from continuing operations before income taxes | 57,475 | 41,057 | 189,059 | 131,751 | |||||||||||
Provision for income taxes | 21,883 | 17,303 | 71,934 | 55,652 | |||||||||||
Income from continuing operations | 35,592 | 23,754 | 117,125 | 76,099 | |||||||||||
Discontinued operations, net of income taxes: | |||||||||||||||
Income (loss) from discontinued operations | (38 | ) | — | (635 | ) | — | |||||||||
Gain (loss) on disposal | 72 | (83 | ) | 241 | 34 | ||||||||||
Income (loss) from discontinued operations | 34 | (83 | ) | (394 | ) | 34 | |||||||||
Net income | $ | 35,626 | $ | 23,671 | $ | 116,731 | $ | 76,133 | |||||||
Basic earnings (loss) per share: | |||||||||||||||
Income from continuing operations | $ | 0.52 | $ | 0.35 | $ | 1.72 | $ | 1.12 | |||||||
Income (loss) from discontinued operations | — | — | (0.01 | ) | — | ||||||||||
Basic earnings per share | $ | 0.52 | $ | 0.35 | $ | 1.71 | $ | 1.12 | |||||||
Diluted earnings (loss) per share: | |||||||||||||||
Income from continuing operations | $ | 0.51 | $ | 0.34 | $ | 1.68 | $ | 1.09 | |||||||
Income (loss) from discontinued operations | — | — | (0.01 | ) | — | ||||||||||
Diluted earnings per share | $ | 0.51 | $ | 0.34 | $ | 1.67 | $ | 1.09 | |||||||
Dividends per share | 0.045 | 0.045 | 0.18 | 0.18 | |||||||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 68,157 | 68,089 | 68,165 | 67,734 | |||||||||||
Diluted | 69,950 | 70,066 | 69,893 | 69,611 | |||||||||||
MAXIMUS, Inc. | ||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
(Dollars in thousands) | ||||||
September 30, | ||||||
2013 | 2012 | |||||
ASSETS | (Unaudited) | |||||
Current assets: | ||||||
Cash and cash equivalents | $ | 125,617 | $ | 189,312 | ||
Restricted cash | 12,176 | 11,593 | ||||
Accounts receivable—billed, net | 272,636 | 172,705 | ||||
Accounts receivable—unbilled | 20,320 | 10,539 | ||||
Prepaid income taxes | 358 | 3,800 | ||||
Deferred income taxes | 26,443 | 22,207 | ||||
Prepaid expenses and other current assets | 32,049 | 33,061 | ||||
Total current assets | 489,599 | 443,217 | ||||
Property and equipment, net | 77,710 | 58,798 | ||||
Capitalized software, net | 40,456 | 27,390 | ||||
Goodwill | 171,867 | 112,032 | ||||
Intangible assets, net | 42,039 | 25,330 | ||||
Deferred contract costs, net | 14,318 | 9,284 | ||||
Deferred income taxes | 1,179 | 1,369 | ||||
Deferred compensation plan assets | 10,314 | 9,220 | ||||
Other assets, net | 10,496 | 8,653 | ||||
Total assets | $ | 857,978 | $ | 695,293 | ||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||
Current liabilities: | ||||||
Accounts payable and accrued liabilities | $ | 109,020 | $ | 73,128 | ||
Accrued compensation and benefits | 83,280 | 56,105 | ||||
Deferred revenue | 53,137 | 45,501 | ||||
Current portion of long-term debt | 170 | 178 | ||||
Income taxes payable | 8,327 | 3,100 | ||||
Other accrued liabilities | 8,373 | 6,599 | ||||
Total current liabilities | 262,307 | 184,611 | ||||
Deferred revenue, less current portion | 32,953 | 34,075 | ||||
Long-term debt | 1,319 | 1,558 | ||||
Acquisition-related contingent consideration, less current portion | 388 | 406 | ||||
Income taxes payable, less current portion | 1,191 | 1,412 | ||||
Deferred income taxes | 16,359 | 10,384 | ||||
Deferred compensation plan liabilities, less current portion | 13,953 | 11,741 | ||||
Total liabilities | 328,470 | 244,187 | ||||
Total shareholders’ equity | 529,508 | 451,106 | ||||
Total liabilities and shareholders’ equity | $ | 857,978 | $ | 695,293 | ||
MAXIMUS, Inc. | ||||||||||||||||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||||||||||||
(Dollars in thousands; Unaudited) | ||||||||||||||||||||||||
Three Months |
Year | |||||||||||||||||||||||
Ended September 30, |
Ended September 30, |
|||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||||||||
Net income | $ | 35,626 | $ | 23,671 | $ | 116,731 | $ | 76,133 | ||||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||||||||||
(Income) loss from discontinued operations | (34 | ) | 83 | 394 | (34 | ) | ||||||||||||||||||
Depreciation and amortization | 10,053 | 7,947 | 35,816 | 26,460 | ||||||||||||||||||||
Deferred income taxes | (634 | ) | 1,355 | 2,396 | (3,274 | ) | ||||||||||||||||||
Stock compensation expense | 3,847 | 3,236 | 14,555 | 12,077 | ||||||||||||||||||||
Changes in assets and liabilities, net of effects of business combinations and divestitures: | ||||||||||||||||||||||||
Accounts receivable — billed | (43,020 | ) | (14,297 | ) | (93,092 | ) | (7,213 | ) | ||||||||||||||||
Accounts receivable — unbilled | (3,984 | ) | 1,996 | (9,905 | ) | 2,214 | ||||||||||||||||||
Prepaid expenses and other current assets | 30 | 2,227 | (2,492 | ) | (6,018 | ) | ||||||||||||||||||
Deferred contract costs | (2,622 | ) | (2,540 | ) | (5,073 | ) | (1,221 | ) | ||||||||||||||||
Accounts payable | 15,198 | 9,759 | 31,678 | 6,485 | ||||||||||||||||||||
Accrued compensation and benefits | 14,367 | 1,372 | 21,308 | (2,648 | ) | |||||||||||||||||||
Deferred revenue | 9,244 | (1,334 | ) | 6,304 | 9,827 | |||||||||||||||||||
Income taxes | (3,955 | ) | (2,656 | ) | 2,034 | 6,885 | ||||||||||||||||||
Other assets and liabilities | (1,721 | ) | (720 | ) | 903 | (4,513 | ) | |||||||||||||||||
Cash provided by continuing operations | 32,395 | 30,099 | 121,557 | 115,160 | ||||||||||||||||||||
Cash used in discontinued operations | (32 | ) | — | (619 | ) | — | ||||||||||||||||||
Cash provided by operating activities | 32,363 | 30,099 | 120,938 | 115,160 | ||||||||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||||||
Acquisition of business, net of cash acquired | (71,435 | ) | — | (71,435 | ) | (66,003 | ) | |||||||||||||||||
Proceeds from settlement of final PSI price | — | — | 3,380 | — | ||||||||||||||||||||
Purchases of property and equipment | (18,711 | ) | (6,485 | ) | (43,580 | ) | (18,369 | ) | ||||||||||||||||
Capitalized software costs | (4,944 | ) | (1,932 | ) | (18,596 | ) | (4,779 | ) | ||||||||||||||||
Proceeds from note receivable | 113 | — | 398 | 299 | ||||||||||||||||||||
Proceeds from sale of discontinued operations | — | — | — | 2,240 | ||||||||||||||||||||
Cash used in investing activities — continuing ops | (94,977 | ) | (8,417 | ) | (129,833 | ) | (86,612 | ) | ||||||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||||||
Cash dividends paid | (3,070 | ) | (3,063 | ) | (12,272 | ) | (12,180 | ) | ||||||||||||||||
Repurchases of common stock | (5,473 | ) | (3,088 | ) | (33,287 | ) | (12,977 | ) | ||||||||||||||||
Stock compensation tax benefit | 5,889 | 3,793 | 10,569 | 7,268 | ||||||||||||||||||||
Tax withholding related to RSU vesting | — | (19 | ) | (8,868 | ) | (4,464 | ) | |||||||||||||||||
Stock option exercises | 328 | 30 | 2,168 | 6,441 | ||||||||||||||||||||
Repayment of long-term debt | (42 | ) | (44 | ) | (172 | ) | (44 | ) | ||||||||||||||||
Acquisition-related contingent consideration | — | (1,809 | ) | — | (1,809 | ) | ||||||||||||||||||
Cash used in financing activities — continuing ops | (2,368 | ) | (4,200 | ) | (41,862 | ) | (17,765 | ) | ||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 2,688 | 2,930 | (12,938 | ) | 5,579 | |||||||||||||||||||
Net increase/(decrease) in cash and cash equivalents | (62,294 | ) | 20,412 | (63,695 | ) | 16,362 | ||||||||||||||||||
Cash and cash equivalents, beginning of period | 187,911 | 168,900 | 189,312 | 172,950 | ||||||||||||||||||||
Cash and cash equivalents, end of period | $ | 125,617 | $ | 189,312 | $ | 125,617 | $ | 189,312 |
MAXIMUS, Inc. | |||||||||||||||||||||||||||
SEGMENT INFORMATION – GAAP Basis | |||||||||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||
Three Months Ended September 30, | Year Ended September 30, | ||||||||||||||||||||||||||
2013 | % (1) | 2012 | % (1) | 2013 | % (1) | 2012 | % (1) | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||||||
Health Services | $ | 271,032 | 100 | % | $ | 181,565 | 100 | % | $ | 862,879 | 100 | % | $ | 671,181 | 100 | % | |||||||||||
Human Services | 113,307 | 100 | % | 119,172 | 100 | % | 468,400 | 100 | % | 378,964 | 100 | % | |||||||||||||||
Total | 384,339 | 100 | % | 300,737 | 100 | % | 1,331,279 | 100 | % | 1,050,145 | 100 | % | |||||||||||||||
Gross Profit: | |||||||||||||||||||||||||||
Health Services | 85,322 | 31.5 | % | 44,533 | 24.5 | % | 248,100 | 28.8 | % | 172,456 | 25.7 | % | |||||||||||||||
Human Services | 32,177 | 28.4 | % | 40,096 | 33.6 | % | 137,933 | 29.4 | % | 115,487 | 30.5 | % | |||||||||||||||
Total | 117,499 | 30.6 | % | 84,629 | 28.1 | % | 386,033 | 29.0 | % | 287,943 | 27.4 | % | |||||||||||||||
Selling, general, and administrative expense: | |||||||||||||||||||||||||||
Health Services | 39,384 | 14.5 | % | 24,551 | 13.5 | % | 118,266 | 13.7 | % | 91,837 | 13.7 | % | |||||||||||||||
Human Services | 20,245 | 17.9 | % | 18,274 | 15.3 | % | 79,842 | 17.0 | % | 65,565 | 17.3 | % | |||||||||||||||
Corporate/Other | 134 | NM | (15 | ) | NM | (249 | ) | NM | — | NM | |||||||||||||||||
Total | 59,763 | 15.5 | % | 42,810 | 14.2 | % | 197,859 | 14.9 | % | 157,402 | 15.0 | % | |||||||||||||||
Operating income from continuing operations: | |||||||||||||||||||||||||||
Health Services | 45,938 | 16.9 | % | 19,982 | 11.0 | % | 129,834 | 15.0 | % | 80,619 | 12.0 | % | |||||||||||||||
Human Services | 11,932 | 10.5 | % | 21,822 | 18.3 | % | 58,091 | 12.4 | % | 49,922 | 13.2 | % | |||||||||||||||
Corporate/Other | (134 | ) | NM | 15 | NM | 249 | NM | — | NM | ||||||||||||||||||
Subtotal: Segment Operating Income | 57,736 | 15.0 | % | 41,819 | 13.9 | % | 188,174 | 14.1 | % | 130,541 | 12.4 | % | |||||||||||||||
Legal, settlement and acquisition-related expenses, net | 668 | NM | 1,846 | NM | 1,966 | NM | 2,966 | NM | |||||||||||||||||||
Total | $ | 57,068 | 14.8 | % | $ | 39,973 | 13.3 | % | $ | 186,208 | 14.0 | % | $ | 127,575 | 12.1 | % | |||||||||||
(1) Percentage of respective segment revenue. Changes not considered meaningful are marked “NM.” |
MAXIMUS, Inc. |
||||
Non-GAAP Measures |
||||
ADJUSTED REVENUE AND OPERATING INCOME |
||||
(Dollars in thousands) |
||||
(Unaudited) |
||||
Year Ended | ||||
September 30, | ||||
2013 | ||||
Total company revenue | $ | 1,331,279 | ||
Revenue from terminated contract | (16,035 | ) | ||
Total company revenue excluding terminated contract | $ | 1,315,244 | ||
Total company operating income | $ | 186,208 | ||
Operating income from terminated contract | (10,900 | ) | ||
Acquisition-related expenses | 2,168 | |||
Legal and settlement recoveries (net) | (202 | ) | ||
Total company operating income, excluding terminated contract, acquisition-related expense, and legal and settlement recoveries | $ | 177,274 | ||
Total company operating margin, excluding terminated contract, acquisition expenses, and legal and settlement recoveries | 13.5 | % | ||
Year Ended | ||||
September 30, | ||||
2013 | ||||
Human Services revenue | $ | 468,400 | ||
Revenue from terminated contract | (16,035 | ) | ||
Human Services revenue, excluding terminated contract | $ | 452,365 | ||
Human Services operating income | $ | 58,091 | ||
Operating income from terminated contract | (10,900 | ) | ||
Human Services operating income, excluding terminated contract | $ | 47,191 | ||
Human Services operating margin, excluding terminated contract | 10.4 | % | ||
MAXIMUS, Inc. | |||||||||||||||
Non-GAAP Measures | |||||||||||||||
ADJUSTED DILUTED EPS FROM CONTINUING OPERATIONS | |||||||||||||||
FY 2013 and FY 2012 | |||||||||||||||
(Unaudited) | |||||||||||||||
Year | |||||||||||||||
Quarter Ended | Ended | ||||||||||||||
Dec. 31, | Mar. 31, | Jun. 30, | Sept. 30, | Sept. 30, | |||||||||||
2012 | 2013 | 2013 | 2013 | 2013 | |||||||||||
Diluted EPS from continuing operations-GAAP basis | $ | 0.31 | $ | 0.45 | $ | 0.40 | $ | 0.51 | $ | 1.68 | |||||
Pro forma adjustments: | |||||||||||||||
Legal, settlement and acquisition-related expenses, net | – | – | 0.01 | – | 0.01 | ||||||||||
Adjustment for terminated contract | – | (0.09) | – | – | (0.09) | ||||||||||
Subtotal pro forma adjustments | – | (0.09) | 0.01 | – | (0.08) | ||||||||||
Adjusted Diluted EPS from continuing operations | $ | 0.31 | $ | 0.36 | $ | 0.41 | $ | 0.51 | $ | 1.60 | |||||
Year | |||||||||||||||
Quarter Ended | Ended | ||||||||||||||
Dec. 31, | Mar. 31, | Jun. 30, | Sept. 30, | Sept. 30, | |||||||||||
2011 | 2012 | 2012 | 2012 | 2012 | |||||||||||
Diluted EPS from continuing operations-GAAP basis | $ | 0.26 | $ | 0.21 | $ | 0.29 | $ | 0.34 | $ | 1.09 | |||||
Pro forma adjustments: | |||||||||||||||
Legal, settlement and acquisition-related expenses, net | – | – | 0.02 | 0.01 | 0.03 | ||||||||||
Adjustment for tax accounts | – | 0.03 | – | 0.02 | 0.06 | ||||||||||
Subtotal pro forma adjustments | – | 0.03 | 0.02 | 0.03 | 0.09 | ||||||||||
Adjusted Diluted EPS from continuing operations | $ | 0.26 | $ | 0.24 | $ | 0.31 | $ | 0.37 | $ | 1.18 | |||||
FREE CASH FLOW | ||||||||||||||||
(Dollars in thousands; Unaudited) | ||||||||||||||||
Three Months | Year | |||||||||||||||
Ended September 30, | Ended September 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Cash provided by operating activities – continuing ops | $ | 32,395 | $ | 30,099 | $ | 121,557 | $ | 115,160 | ||||||||
Purchases of property and equipment | (18,711 | ) | (6,485 | ) | (43,580 | ) | (18,369 | ) | ||||||||
Capitalized software costs | (4,944 | ) | (1,932 | ) | (18,596 | ) | (4,779 | ) | ||||||||
Free cash flow | $ | 8,740 | $ | 21,682 | $ | 59,381 | $ | 92,012 | ||||||||